Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A5 | Q15758 | 3/20 | 0.36 |
| ▸ | BMP1 | P13497 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | LTB4R2 | Q9NPC1 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | PPARG | P37231 | 3/20 | 0.33 |
| ▸ | PPARA | Q07869 | 3/20 | 0.33 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.33 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | ACACA | Q13085 | 1/20 | 0.32 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2637405 | 0.85 | FABP5 (0.39) | BMP1MEN1KMT2APPARGPPARA | |
| SCHEMBL7185186 | 0.85 | NPC1 (0.34) | BMP1HSD17B10LTB4R2MEN1KMT2A | |
| SCHEMBL7815464 | 0.83 | BMP1 (0.33) | BMP1LTB4R2MEN1KMT2AMDM2 | |
| SCHEMBL1644285 | 0.83 | MEN1 (0.35) | BMP1LTB4R2MEN1KMT2AMDM2 | |
| SCHEMBL3386401 | 0.82 | MDM2 (0.41) | MEN1KMT2AMDM2NPC1RAB9A | |
| SCHEMBL5330706 | 0.82 | NPC1 (0.36) | BMP1HSD17B10LTB4R2MEN1KMT2A | |
| SCHEMBL3433024 | 0.82 | HSD17B10 (0.39) | BMP1HSD17B10MEN1KMT2AFABP5 | |
| SCHEMBL7557772 | 0.81 | NPC1 (0.35) | BMP1HSD17B10LTB4R2MEN1KMT2A | |
| SCHEMBL28069712 | 0.81 | FABP5 (0.45) | MEN1KMT2AFABP5NPC1RAB9A | |
| SCHEMBL3805522 | 0.80 | BMP1 (0.37) | BMP1MEN1KMT2APPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030087821-A1 | Using exendrin, or antagonist thereof; appetite control | ASTRAZENECA PHARMACEUTICALS LP | 2003-05-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030087821-A1 | Using exendrin, or antagonist thereof; appetite control | GIPR, GLP1R, GPR119 | SLC1A5 767/4885BMP1 3420/4885HSD17B10 2038/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.